Objective Juvenile idiopathic inflammatory myopathies (JIIM) are a group of connective
tissue disorders characterized by muscle inflammation and variable systemic involvement …

Abstract Since December 2019 SARS-CoV-2 infections have affected millions of people
worldwide. Along with the increasing number of COVID-19 patients, the number of cases of …

Coronavirus disease 2019 (COVID-19) may occur with concurrent infections caused by
bacterial and fungal microorganisms. This systematic review evaluated studies reporting …

There is no clear consensus in the literature regarding the choice of biologic therapies and
efficacy in juvenile dermatomyositis (JDM). In this review, we aimed to examine previous …

Background This study retrospectively analyzed the laboratory data and chest images of
patients with amyopathic dermatomyositis associated with interstitial lung disease (ADM …

The admitted patients of intensive care units with coronavirus disease 2019 (COVID-19)
meet the challenges of subsequent infections. Opportunistic fungal infections such as …

Objective: To determine the short-term effectiveness and safety of baricitinib in children with
refractory and/or severe juvenile dermatomyositis (rsJDM) in a real-world setting. Methods …

Since the early phases of the COVID-19 pandemic, it has become clear that children are
affected by mild respiratory symptoms rather than the critical pneumonia typical in adults …

Background Pneumocystis jirovecii pneumonia (PCP) is a serious, emerging complication of
coronavirus disease 2019 (COVID-19). Methods We performed a systematic review of …

Abstract Background/Objectives Janus kinase (JAK) inhibitors have been increasingly used
in the treatment of juvenile dermatomyositis (JDM). This review aims to comprehensively …